Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Schaeffer

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
NPJ Precision Oncology|April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancerAbdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Iscience|August 12, 2025
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinomaJames T Topham, Joanna M Karasinska, Andrew Metcalfe, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
JAMA Oncology|July 17, 2015
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and BeyondSamantha Hansford, Pardeep Kaurah, Hector Li-Chang, et al.
The Journal of Pathology. Clinical Research|March 8, 2022
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignanciesBasile Tessier-Cloutier, Jasleen K Grewal, Martin R Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2024
Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson DiseaseNadarra L Stokes, Ameya Patil, Oyedele Adeyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal AdenocarcinomaMartin R Jones, Laura M Williamson, James T Topham, et al.
Nature Communications|October 8, 2022
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinomaJames T Topham, Erica S Tsang, Joanna M Karasinska, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Base excision repair deficiency signatures implicate germline and somatic <i>MUTYH</i> aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesisMy Linh Thibodeau, Eric Y Zhao, Caralyn Reisle, et al.
Nature Genetics|February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
NPJ Precision Oncology|April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancerAbdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Iscience|August 12, 2025
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinomaJames T Topham, Joanna M Karasinska, Andrew Metcalfe, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
JAMA Oncology|July 17, 2015
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and BeyondSamantha Hansford, Pardeep Kaurah, Hector Li-Chang, et al.
The Journal of Pathology. Clinical Research|March 8, 2022
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignanciesBasile Tessier-Cloutier, Jasleen K Grewal, Martin R Jones, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2024
Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson DiseaseNadarra L Stokes, Ameya Patil, Oyedele Adeyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal AdenocarcinomaMartin R Jones, Laura M Williamson, James T Topham, et al.
Nature Communications|October 8, 2022
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinomaJames T Topham, Erica S Tsang, Joanna M Karasinska, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Base excision repair deficiency signatures implicate germline and somatic <i>MUTYH</i> aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesisMy Linh Thibodeau, Eric Y Zhao, Caralyn Reisle, et al.
Nature Genetics|February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Pageof 18